CD34(-COLONY-STIMULATING FACTOR (G-CSF) ARE FUNCTIONALLY DIFFERENT FROM CD34(+) CELLS MOBILIZED BY G-CSF() CELLS MOBILIZED BY CYCLOPHOSPHAMIDE AND GRANULOCYTE)
C. Cesana et al., CD34(-COLONY-STIMULATING FACTOR (G-CSF) ARE FUNCTIONALLY DIFFERENT FROM CD34(+) CELLS MOBILIZED BY G-CSF() CELLS MOBILIZED BY CYCLOPHOSPHAMIDE AND GRANULOCYTE), Bone marrow transplantation, 21(6), 1998, pp. 561-568
Mobilized peripheral blood progenitor cells (PBPC) are increasingly us
ed as an alternative to bone marrow for autografting procedures. Curre
ntly, cyclophosphamide (CY) followed by granulocyte colony-stimulating
factor (G-CSF) or G-CSF alone are the most commonly used PBPC mobiliz
ation schedules, In an attempt to investigate whether the use of these
two mobilization regimens could result in the collection of functiona
lly different CD34(+) cells, we analyzed nucleated cells (NC), CD34(+)
cells, committed progenitor cells and long-term culture initiating-ce
lls (LTC-IC) in 52 leukaphereses from 26 patients with lymphoid malign
ancies, mobilized either by CY+G-CSF (n = 16) or G-CSF alone (n = 10).
Thirty-four aphereses from the CY+G-CSF group and 18 aphereses from t
he G-CSF group were investigated, According to the study design, leuka
phereses were carried out until an average number of 7 x 10(6) CD34(+)
cells/kg body weight were collected. The mean (+/- s.e.m.) numbers of
CD34(+) cells mobilized per apheresis by CY+G-CSF and G-CSF were not
significantly different (2.76 +/- 0.6 x 10(8) vs 2.53 +/- 0.4 x 10(8),
P less than or equal to 0.7). This resulted from a mean number of NC
that was significantly lower in the CY+G-CSF products than in the G-CS
F products (12.4 +/- 1.7 x 10(9) vs 32 +/- 5.4 x 10(9), P less than or
equal to 0.0001) and a mean incidence of CD34(+) cells that was signi
ficantly higher in the CY+G-CSF products than in the G-CSF products (2
.9 +/- 0.6% vs 0.9 +/- 0.2%, P less than or equal to 0.0018). The mean
(+/- s.e.m.) number of CFU-GM collected per apheresis was significant
ly higher in the CY+G-CSF group than in the G-CSF group (37 +/- 7 x 10
(6) vs 14 +/- 2 x 10(6), P less than or equal to 0.03). Interestingly,
CY+G-CSF-mobilized CD34(+) cells had a significantly higher plating e
fficiency than G-CSF-mobilized CD34(+) cells (25.5 +/- 2.9% vs 10.8 +/
- 1.9%, P less than or equal to 0.0006). In addition, the mean number
of LTC-IC was significantly higher in the CY+G-CSF products than in th
e G-CSF products (6.3 +/- 1 x 10(6) vs 3.3 +/- 0.3 x 10(6), P less tha
n or equal to 0.05). In conclusion, our data provide evidence that CYG-CSF and G-CSF induce the mobilization of CD34(+) cells with differen
t clonogenic potential, As mobilized PBPC containing large numbers of
progenitors lead to safer transplantation, this issue may have implica
tions for planning mobilization strategies.